Mohit Nanda, MD
Retina Specialist · Charlottesville, VANPI 1750363396
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (54.0%), ownership interests and food and beverage — rather than concentrated in one kind of arrangement. US Retina LLC accounts for 92.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $17,150 and has fallen 95.8% since, to $717 in 2025. Among retina specialist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $446.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$29K
- Regeneron Healthcare Solutions, Inc.$812
- Genentech USA, Inc.$341
- Alimera Sciences, Inc.$306
- Apellis Pharmaceuticals, Inc.$216
- Astellas Pharma US Inc$187
- plus $323 from 5 others
What the payments were for
- Food & beverage$2,1837%
- Ownership interest$11,98639%
- Other$16,62954%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 7 | $28,615 |
| Regeneron Healthcare Solutions, Inc. | 20 | $812 |
| Genentech USA, Inc. | 13 | $341 |
| Alimera Sciences, Inc. | 5 | $306 |
| Apellis Pharmaceuticals, Inc. | 8 | $216 |
| Astellas Pharma US Inc | 3 | $187 |
| AbbVie | 8 | $162 |
| Lilly USA, LLC | 2 | $91 |
| Harrow Eye, LLC | 1 | $32 |
| Misonix Inc | 1 | $25 |
| Bausch & Lomb Americas Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$30,799 in reported general payments places this provider in the 95th percentile of 41 retina specialist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 74 | $1,721 |
| Latanoprost | 74 | $799 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 34 | $625 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Charlottesville
- Hayley JamesCharlottesville$5K
- Jacob MeyerCharlottesville$2K
- Michael CusickCharlottesville$2K
- Jordana FeinManassas$412K
- Joaquin TosiVirginia Beach$48K
- Muge KesenMc Lean$30K
- Anna MackinRoanoke$26K
- Jon AdlebergChesapeake$21K
- Dal ChunVienna$12K
- Kori ElkinsPortsmouth$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.